Investing Profile
Mark Sullivan
Your Intro Paths to Mark Sullivan
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Mark is a member of
GSK Network
45 CONNECTIONS
Gilead Sciences Network
20 CONNECTIONS
GlaxoSmithKline Network
19 CONNECTIONS
Current Investing Position
Adjuvant Capital Venture Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Current Fund Size
$300M
Mark Sullivan is on these Sector & Stage Rankings
Pharmaceuticals (Seed)Consumer Health (Series A)BioTech (Seed)Consumer Health (Seed)Pharmaceuticals (Series A)Health IT (Series A)BioTech (Series A)Health & Hospital Services (Series A)Diagnostics (Series A)Diagnostics (Seed)Health IT (Seed)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)
Mark Sullivan's Experience
Research Scientist Johnson MattheyPresent
Clinical Program Head GlaxoSmithKlinePresent
Clinical Program Head GSKPresent
Director, Asia Pacific i3 ResearchPresent
Associate Director, Clinical Research Gilead SciencesPresent
Managing Director Medicines Development for Global HealthPresent
Lecturer Melbourne Business SchoolPresent
Honorary Professor UNSW Civil and Environmental EngineeringPresent
Senior Advisor Global Health FundsPresent
Venture Partner Adjuvant CapitalPresent
Investors who invest with Mark Sullivan
Sign in with Google →Scouts & Angels Affiliated With Mark Sullivan
Sign in with Google →